GlassScriptPhysician profile
Dusan Perisic
NPI 1073767026
$5,906.25
in general payments reported to CMS, 2019-2025
17 companies · $3,612 in 2025
The $3,612 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $106 · 2021: $234 · 2022: $412 · 2023: $407 · 2024: $130 · 2025: $3,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $1,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $1,648.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $2,794.72 | 2022-2025 | Coolseal Generator, Myosure Tissue Removal Device, Acessa Provu System |
| Intuitive Surgical, INC. | $1,178.98 | 2019-2023 | Da Vinci Surgical System |
| Davol INC. | $1,001.97 | 2020-2025 | Arista, Arista Ah Flexitip, Surgiphor |
| Daiichi Sankyo INC. | $198.71 | 2021-2023 | Injectafer |
| Pfizer INC. | $124.56 | 2021-2024 | |
| Conmed Corporation | $102.17 | 2022-2025 | Airseal |
| Abbvie INC. | $97.41 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $91.51 | 2023-2024 | Myfembree |
| Medtronic, INC. | $69.04 | 2022 | |
| Myovant Sciences INC. | $61.15 | 2021-2022 | |
| Aspira Women'S Health INC | $57.08 | 2025 | Ova1 |
| Meditrina | $44.41 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.89 | 2022 | |
| Astellas Pharma US INC | $18.22 | 2024 | Veozah |
| Millicent US INC | $16.33 | 2025 | Femlyv |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $15.57 | 2022 | |
| Exeltis, USA INC. | $14.53 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dusan Perisic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.